---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-003309"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:47:25.361570+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics prices $6.0M public offering of shares and warrants

## Summary
- Raised $6.0M gross ($5.2M net) from sale of 1.5M share equivalents and warrants at $4.00/unit.
- Offering includes Series A (5-year) and Series B (12-month) warrants, each exercisable at $4.00/share.
- Placement agent H.C. Wainwright receives 7% cash fee plus 105,000 placement agent warrants at $5.00.
- Net proceeds to fund pre-clinical studies and general corporate purposes.
- Offering closed on Sept 12, 2025; securities registered under Form S-1 effective Sept 11.

## SEC filing metadata
- accession: 0001178913-25-003309
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/0001178913-25-003309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/zk2533780.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-003309
- JSON: https://secwatch.observer/filing/0001178913-25-003309.json
- Plain text: https://secwatch.observer/filing/0001178913-25-003309.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.